Dr. Vishal Kapur, MD

Dr. Kapur practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Kapur's NPI, 1730383308, was assigned on June 14, 2007. Dr. Kapur holds New York license 260306.

Dr. Kapur's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Kapur also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Kapur's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Kapur is also affiliated with Mount Sinai West. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Kapur to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kapur practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kapur's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kapur is licensed in New York.

CMS data shows 1,449 Medicare services from Dr. Kapur across 19 procedure codes in 2024, for 525 Medicare patients. Medicare paid $157,702 for them.

CMS counts 525 Medicare patients who saw Dr. Kapur in 2024. The largest group is 75 to 84, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kapur's median patient age at 67, with 60% women.

In 2024, Dr. Kapur wrote 830 Medicare Part D claims for 184 patients. 82% of them were for generic drugs. CMS names the drug for 682 of them, across 20 drugs with 11 or more claims each, at $95,347 in total drug cost. In 2023, CMS named 863 claims across 23 drugs.

Dr. Kapur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 146 procedures of varicose vein removal by Dr. Kapur, more than 88% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Kapur, published from 2014 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Coronary Angiography. Dr. Kapur has published most often in Catheter Cardiovasc Interv. Dr. Kapur's most frequent co-authors are Annapoorna S. Kini, MD, Samin Sharma, MD and Samin Sharma, MD.

Dmand AI links Dr. Kapur to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 1,653 general payments to Dr. Kapur from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Abbott Laboratories paid the most, $50,202.